Holen Sie sich die Stockscreener-App
50.97
1.45%
0.73
Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten
Bank of New York Mellon Corp Sells 680 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Insider Sell Alert: EVP, Head of North America Jennifer Lee Sells Shares of Rhythm Pharmaceuticals Inc (RYTM) - GuruFocus.com
How To Trade (RYTM) - Stock Traders Daily
SBI Securities Co. Ltd. Invests $37,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target By Investing.com - Investing.com Canada
Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Overweight Rating from Morgan Stanley - Defense World
Assessing Rhythm Pharmaceuticals: Insights From 10 Financial Analysts - Benzinga
Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Study Expectations and Market Potential - TipRanks
Stifel Nicolaus Begins Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $68.27 - Defense World
Citizens JMP maintains Rhythm Pharma Outperform, $81 target By Investing.com - Investing.com South Africa
HC Wainwright Brokers Raise Earnings Estimates for RYTM - Defense World
Citizens JMP maintains Rhythm Pharma Outperform, $81 target - Investing.com India
Principal Financial Group Inc. Purchases 4,298 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Brokers Issue Forecasts for RYTM FY2026 Earnings - Defense World
Promising Market Potential for Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity - TipRanks
Stifel raises Rhythm Pharmaceuticals stock to Buy with $78 target By Investing.com - Investing.com Canada
US High Growth Tech Stocks to Watch in March 2025 - Yahoo Finance
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates - MSN
Y Intercept Hong Kong Ltd Invests $328,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
HC Wainwright Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - Defense World
Rhythm Pharmaceuticals Faces Financial Risks Due to Convertible Preferred Stock Prioritization - MSN
Rhythm Pharmaceuticals stock target raised to $70 at H.C. Wainwright - Investing.com India
Learn to Evaluate (RYTM) using the Charts - Stock Traders Daily
Decoding Rhythm Pharmaceuticals Inc (RYTM): A Strategic SWOT Ins - GuruFocus.com
Needham & Company LLC Reaffirms “Buy” Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $81.00 - MarketBeat
Rhythm Pharmaceuticals sets annual meeting for June 24 By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals sets annual meeting for June 24 - Investing.com
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Needham & Company LLC - MarketBeat
RHYTHM PHARMACEUTICALS, INC. SEC 10-K Report - TradingView
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Purchased by Rhumbline Advisers - Defense World
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks
Citizens JMP raises Rhythm Pharma stock target to $81 By Investing.com - Investing.com Canada
State of New Jersey Common Pension Fund D Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals: Strong Buy Rating Backed by IMCIVREE’s Growth and Promising Pipeline Developments - TipRanks
Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating - Investing.com UK
We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth - Yahoo Finance
Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highligh - GuruFocus.com
Rhythm Pharmaceuticals Reports Strong 2024 Growth and Strategic Advances - TipRanks
Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Rhythm Pharmaceuticals: Strong Commercial Execution and Promising Pipeline Drive Buy Rating - TipRanks
Earnings call transcript: Rhythm Pharmaceuticals Q4 2024 beats earnings forecast - Investing.com
Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases -February 26, 2025 at 07:32 am EST - Marketscreener.com
Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Revenue $41.8M, vs. FactSet Est of $38.5M - Marketscreener.com
Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Net Loss $0.72 a Share, vs. FactSet Est of $0.69 Loss - Marketscreener.com
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - TradingView
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business ... - The Bakersfield Californian
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):